BCK Capital Management’s SpringWorks Therapeutics SWTX Stock Holding History

BCK Capital Management’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-20,000	Closed	-$940K	–	112
2025 Q2	$940K	Buy	+20,000	New	+$890K	0.81%	41

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

BCK Capital Management's SWTX Position: Q3 2025 in Review

BCK Capital Management sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 20,000 shares — an estimated $940K sold.

BCK Capital Management first reported a position in SWTX in Q2 2025 and held it in 1 quarter. The position peaked at $940K in Q2 2025. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

BCK Capital Management reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
BCK Capital Management sold 20,000 SpringWorks Therapeutics shares in Q3 2025, an estimated $940K.
BCK Capital Management first reported a position in SpringWorks Therapeutics in Q2 2025 and held it in 1 quarter.
BCK Capital Management's SpringWorks Therapeutics position peaked at $940K in Q2 2025.
3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on BCK Capital Management's 13F filing for Q3 2025, filed 10 Nov 2025.